Animal health is defined as a term that covers animal diseases and the relationship between animal welfare, environment protection, human health, and food safety. Animal health are used for sustaining the healthy development of animals. The main products in animal health market are vaccines, pharmaceuticals, medicinal feed additives, diagnostics, equipment and disposables and others. Commercial animals or livestock can be defined as living animals that are grown or raised for commercial purposes. Animal health is used for improving the productivity of commercial animals, extracting income, and keeping all animals disease free. These are used by commercial and companion animal types through oral, parenteral and topical route of administration. These are used by various end users such as veterinary hospitals and clinics, animal care and rehabilitation centers and diagnostic centers. The global animal health market is segmented - 1) By Product: Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Equipment And Disposables, Other Products 2) By Animal Type: Commercial, Companion 3) By Route Of Administration: Oral, Parenteral, Topical 4) By End-User: Veterinary Hospitals And Clinics, Animal Care And Rehabilitation Centers, Diagnostic Centers The global animal health market size is expected to grow from $46.95 billion in 2022 to $50.99 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global animal health market size is expected to reach $70.17 billion in 2027 at a CAGR of 8.31%. The increasing prevalence of zoonotic diseases will support the growth of the animal health market going forward. Zoonotic diseases can be defined as infectious diseases that can be transmitted between different animal species to humans or from humans to animals. Monitoring and safeguarding animal health using different methods helps in controlling zoonosis and can help in protecting public health. For instance, according to World Health Organization, a Switzerland-based specialized agency of the United Nations, in Africa, there was an increase of 63% in the number of zoonotic outbreaks from 2012-2022 as compared to last decade. Zoonotic diseases cause 2.5 billion cases of human illness and 2.7 million human deaths every year globally. Therefore, the increasing prevalence of zoonotic diseases will propel the animal health market. Major players in the animal health market are Elanco Animal Health Incorporated, Merck Animal Health, Zoetis Inc., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Heska Corporation, Vetoquinol SA, Virbac, Bayer AG, Novartis , Biogenesis Bago, Intervet International BV, IDEXX Laboratories Inc., Hester Biosciences Ltd., and Intas Pharmaceuticals Ltd. Technological advancements are the key trends gaining popularity in the animal health market. Major market players are concentrating their efforts on introducing new and advanced technologies to strengthen their position in the market. For instance, in April 2022, Elanco Animal Health Incorporated, a US-based animal health company, and Ginkgo Bioworks, a US-based biotechnology company, launched October 2022, Merck Animal Health, a US-based company that develops, manufactures, and markets a broad range of veterinary medicines and services launched Animo GPS, an activity and behaviour monitor for dogs with GPS tracking capabilities. The product enables real-time tracking with position updates starting every five seconds when in "Lost Dog Mode" and may notify pet owners within 20 seconds if their dog exits its assigned "Safe Zone." Smart technology is used by Animo GPS to track a dog's individual activity levels and behaviour within an intuitive mobile app. Data on barking, scratching, shaking, and sleep duration are all recorded by the device. If there are any major changes in these behaviours, it can utilize an adaptive algorithm to analyze this information and issue an alert via the app In July 2022, Dechra Pharmaceuticals plc, a UK-based business involved in the development and marketing of veterinary products acquired Piedmont Animal Health for $210 million. With this acquisition, Dechra Pharmaceuticals plc will entirely be focused on growing the human health business. Piedmont Animal Health is a US-based specialty pharmaceutical company focused on human and animal health therapeutics. North America was the largest region in the animal health market in 2022. The regions covered in the global animal health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the animal health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The animal health market consists of sales of biologics and flea and tick medications. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products. The animal health market research report is one of a series of new reports from The Business Research Company that provides animal health market statistics, including animal health industry global market size, regional shares, competitors with an animal health market share, detailed animal health market segments, market trends, and opportunities, and any further data you may need to thrive in the animal health industry. This animal health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Animal drug compounding is defined as the process of mixing and altering the ingredients of multiple medicines to create a customized medicine to treat the specific needs of a single animal or multiple animals. It is used for providing medical treatment for animals and is a process that plays an important role in veterinary medicine. The main animal drug compounding products are anti-infective agents, anti-inflammatory agents, hormones and substitutes, CNS agents, and other products. Anti-infective agents can be defined as medicines that are used to prevent various infections, such as antibiotics, antivirals, antifungals, and others. Anti-infective agents are used in animal drugs to kill infectious germs and stop the spread of infection in animals. The animal drug compounding is used for several types of animals, such as companion animals and livestock animals and administered through various routes, including oral, injectable, topical, and others. It is used in veterinary hospitals, veterinary clinics, and veterinary diagnostic centers. The global animal drug compounding market is segmented - 1) By Animal Type: Companion Animals, Livestock Animals 2) By Product: Anti-infective Agents, Anti-inflammatory Agents, Hormones And Substitutes, CNS Agents, Other Products 3) By Route of Administration: Oral, Injectable, Topical, Other Routes Of Administration 4) By Application: Veterinary Hospitals, Veterinary Clinics, Veterinary Diagnostic Centers The global animal drug compounding market size is expected to grow from $1.44 billion in 2022 to $1.56 billion in 2023 at a compound annual growth rate (CAGR) of 8.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global animal drug compounding market size is expected to reach $2.07 billion in 2027 at a CAGR of 7.3%. A rise in the rate of animal adoption is expected to propel the growth of the animal drug compounding market going forward. Animal adoption is defined as acquiring animals through rescue groups instead of purchasing them from pet shops or breeders. Adopted animals may have pre-existing health conditions or may require medications that are not available in standard formulations, which create a demand for customized animal medications. As more pet owners may seek customized medications for their adopted animals, the need for animal drug compounding increases. For instance, in 2021, according to Chewy, Inc., a US-based online retailer of pet food and other products, there were around 977,202 pets adopted in the US in 2021, which resulted in the highest adoption rate of 61% in the past six years. Moreover, in November 2022, according to a national survey of pets and people published by Animal Medicines Australia (AMA), an Australia-based industry body representing the leaders of the animal health industry in Australia, in 2022, 48% of Australian households had dogs, up from 40% in 2019. Therefore, the rise in the rate of animal adoption is driving the growth of the animal drug compounding market. Major players in the animal drug compounding market are Wedgewood Pharmacy, Triangle Compounding Pharmacy, Davis Islands Pharmacy & Compounding Lab, CustomMed Compounding Pharmacy, Central Compounding Center South, Wellness Compounding Pharmacy of Cary, Miller's Pharmacy, Caringbah Compounding Pharmacy, Smith's Compounding Pharmacy, Specialist Compounding Pharmacy Pte Ltd., Tache Pharmacy, Hoye's Pharmacy, Vertisis Custom Pharmacy, Smith Caldwell Drug Store, and Sixth Avenue Medical Pharmacy. Product innovations are a key trend gaining popularity in the animal health market. Major market players are concentrating their efforts on introducing new and advanced products to strengthen their position in the market. For instance, in June 2020, Evonik, a US-based specialty chemicals company launched RESOMER, a precise platform of bespoke functional polymeric excipients to give pharmaceutical firms the ability to precisely and accurately manage the release profile of their parenteral medicinal products. The new RESOMER® platform will aid in optimizing drug product stability and so further lowering the regulatory risk for a variety of complicated parenteral drug products. RESOMER® Precise can be used with more than 20 high and low molecular weight polymers from Evonik's market-dominating RESOMER® portfolio, including PLA (Poly (D, L-lactide) and PLGA (Poly (D, L-lactide-co-glycolide). In August 2020, Wedgewood Pharmacy, a US-based animal-health compounding pharmacy, acquired Wildlife Pharmaceuticals and its subsidiary ZooPharm for an undisclosed amount. The acquisition provided Wedgewood with the means to provide treatments for wildlife, increase its revenue, build and expand customer relationships, and spur research and new product development. Zoopharm is a US-based veterinary compounding pharmacy that provides veterinary anesthesia and pain management medications. North America was the largest region in the animal drug compounding market in 2022. The regions covered in the global animal drug compounding market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the animal drug compounding market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The animal drug compounding market consists of sales of flavored medications, suppositories, and ophthalmic preparations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The animal drug compounding market research report is one of a series of new reports from The Business Research Company that provides animal drug compounding market statistics, including animal drug compounding industry global market size, regional shares, competitors with a animal drug compounding market share, detailed animal drug compounding market segments, market trends and opportunities, and any further data you may need to thrive in the animal drug compounding industry. This animal drug compounding market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Veterinary imaging is a diagnostic tool that allows veterinarians to obtain detailed images of internal structures of the animal's body to help identify and diagnose medical conditions. The main products of veterinary imaging are veterinary imaging instruments, veterinary software, and veterinary imaging reagents. Veterinary imaging instruments are defined as instruments that are non-invasive and economical in nature that are used for diagnosing diseases in animals, used for providing clear and detailed images of internal organs and bones of animals to improve animal care. It is used for small companion animals and large animals for orthopedics and traumatology, oncology, cardiology, and neurology applications by veterinary clinics and hospitals, and others. The global veterinary imaging market is segmented - 1) By Product: Veterinary Imaging Instruments, Veterinary Software, Veterinary Imaging Reagents 2) By Animal Type: Small Companion Animals, Large Animals 3) By Application: Orthopaedics And Traumatology, Oncology, Cardiology, Neurology 4) By End-Use: Veterinary Clinics And Hospitals, Other End-Uses The global veterinary imaging market size is expected to grow from $1.59 billion in 2022 to $1.74 billion in 2023 at a compound annual growth rate (CAGR) of 9.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global veterinary imaging market size is expected to reach $2.36 billion in 2027 at a CAGR of 7.9%. The rising prevalence of veterinary diseases is expected to propel the growth of the veterinary imaging market going forward. Veterinary diseases can be defined as diseases and conditions that can affect the health of livestock, domestic pets, and wildlife. As the population of companion animals and livestock animals continues to grow, there has been an increase in the incidence of various diseases and conditions that require diagnostic imaging for proper diagnosis and treatment. Veterinary imaging uses diagnostic imaging to provide care to animals suffering from various diseases and ailments. For instance, according to a 2020 article published by the World Trade Organization, a Switzerland-based intergovernmental organization, 20% of global livestock production is lost every year due to various animal diseases. Therefore, the rising prevalence of veterinary diseases is driving the growth of the veterinary imaging market. Major players in the veterinary imaging market are Agfa-Gevaert N.V., Canon Inc., Carestream Health, Draminski S.A., E.I. Medical Imaging, Esaote S.P.A., Fujifilm Holdings Corporation, GE Healthcare, Heska Corporation, IDEXX Laboratories Inc., Konica Minolta Inc., MinXray Inc., Clarius Mobile Health, Shenzhen Ricso Technology Co. Ltd., and ClearVet Digital Radiography Systems. Product innovations are a key trend gaining popularity in the veterinary imaging market. Major market players are concentrating their efforts on introducing new and innovative products to strengthen their position in the market. For instance, in January 2023, Esaote SpA, an Italy-based medical diagnostic equipment manufacturing company, introduced the Magnifico Vet MRI system, a new and unique imaging solution to provide diagnostics for veterinary hospitals. The MagnificoTM Vet MRI system is environmentally friendly as it is created with long-lasting green permanent magnet technology, is cryogen-free, and consumes a lot less power than superconducting systems. It is outfitted with cutting-edge technologies that provide imaging versatility across a wide range of clinical applications, such as Metal Artefact Reduction (MAR), which enables visualization for post-surgical imaging, particularly when microchips are present, and Speed Up and TR Reduction, advanced data acquisition algorithms that shorten exam times. In July 2022, Zomedica Corp, a US-based veterinary health company offering diagnostic and therapeutic products for companion animals, acquired Revo Squared LLC for an undisclosed amount. Through this acquisition, Zomedica Corp will leverage Revo's innovative MicroView digital cytology platform to provide veterinarians with excellent image quality. Revo Squared LLC is a US-based medical equipment manufacturer, including veterinary imaging devices. North America was the largest region in the veterinary imaging market in 2022. The regions covered in the global veterinary imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the veterinary imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The veterinary imaging market consists of revenues earned by entities by providing imaging services such as ultrasonography, magnetic resonance imaging, and fluoroscopy. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary imaging market also includes sales of nuclear medicine, which are used in providing veterinary imaging services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The veterinary imaging market research report is one of a series of new reports from The Business Research Company that provides veterinary imaging market statistics, including veterinary imaging industry global market size, regional shares, competitors with an veterinary imaging market share, detailed veterinary imaging market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary imaging industry. This veterinary imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pet cancer therapeutics involve the use of various treatments and medications to manage or cure cancer in pets. These therapeutics depend on several factors such as the type and stage of cancer, along with the pet's age and overall health. The main pet cancer therapeutics cancer types are melanoma, mast cell cancer, lymphoma, and mammary and squamous cell cancer. Melanoma refers to a type of cancer that arises from pigment-producing cells called melanocytes. The various route of administration are oral, and injection for dogs, cats, and others. The various therapies are chemotherapy, radiation therapy, immunotherapy, tomo therapy, and others used by veterinary hospitals, clinical pharmacies, retail pharmacies, online pharmacies, and others. The global pet cancer therapeutics market is segmented - 1) By Cancer Type: Melanoma, Mast Cell Cancer, Lymphoma, Mammary And Squamous Cell Cancer 2) By Route of Administration: Oral, Injection 3) By Species: Dogs, Cats, Other Species 4) By Therapy: Chemotherapy, Radiation Therapy, Immunotherapy, TomoTherapy, Other Therapies 5) By End User: Veterinary Hospitals, Clinical Pharmacies, Retail Pharmacies, Online Pharmacies, Other End Users The global pet cancer therapeutics market size is expected to grow from $0.31 billion in 2022 to $0.35 billion in 2023 at a compound annual growth rate (CAGR) of 12.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global pet cancer therapeutics market size is expected to reach $0.53 billion in 2027 at a CAGR of 10.8%. The increasing prevalence of pet cancer is expected to propel the growth of the pet cancer therapeutics market going forward. Pet cancer refers to the development of abnormal and uncontrolled cell growth in the body of a domesticated animal, such as a dog or cat, leading to the formation of a tumor. The increased prevalence of pet cancer is mostly driven by exposure to environmental toxins and pollutants, whereas genetic and lifestyle factors, as a result demand for more advanced and effective cancer therapeutics for pets is expected to increase. According to the Veterinary Cancer Society (VCS) predictions for 2022, it was estimated that 1 in 4 dogs are diagnosed with cancer during their lifetime, with cancer being the primary cause of death among older pets. Also, according to the National Cancer Institute, the federal government's primary agency, approximately 6 million new cases of cancer are diagnosed in each species annually, and this number is expected to increase in the coming years. Therefore, an increasing prevalence of pet cancer will fuel the pet cancer therapeutics market growth. Major players in the pet cancer therapeutics market are AB Science, Boehringer Ingelheim GmbH, Elanco Animal Health, ELIAS Animal Health, Zoetis, Aratana Therapeutics Inc., Anivive, Qbiotics, Regeneus Ltd., VetDC, PetCure Oncology, Karyopharm, Torigen Pharmaceuticals Inc., Virbac, and Nippon Zenyaku Kogyo Co Ltd. Technological advancement has emerged as a key trend gaining popularity in the pet cancer therapeutics market. Major players are focusing their efforts on developing innovative technologies to strengthen their position in the market. For instance, in May 2021, PetDx, a US-based biotech company in the animal health industry, launched a new technology known as OncoK9™. This technology is a blood-based multi-cancer early detection (MCED) test that has been specifically developed for dogs. It is uniquely designed with cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology to offer new cancer-detection capabilities. In June 2021, Elanco a US-based animal health company acquired Kindred Biosciences for an undisclosed amount. This acquisition will allow Elanco to expand its portfolio of animal health products and access new technologies and development platforms. Kindred Biosciences is a US-based biopharmaceutical company specializing in the development of innovative treatments for pets. North America was the largest region in the pet cancer therapeutics market in 2022. The regions covered in the global pet cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pet cancer therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The pet cancer therapeutics market consists of revenues earned by entities by surgery and palliative care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The pet cancer therapeutics market research report is one of a series of new reports from The Business Research Company that provides pet cancer therapeutics market statistics, including pet cancer therapeutics industry global market size, regional shares, competitors with a pet cancer therapeutics market share, detailed pet cancer therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the pet cancer therapeutics industry. This pet cancer therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Spay and neuter are medical procedures performed on cats and dogs to prevent them from reproducing. A spay is defined as the process of removing the ovaries, fallopian tubes, and uterus from a female cat or dog while a neuter is defined as the process of removing the testes from a male dog or cat. The main animal types of spay and neuter are dogs, cats, and other animals. A dog can be defined as a four-legged animal that is a pet animal, for guarding, or for hunting purposes. The various provider types include veterinary clinics and hospitals, others. These are used by various end-users such as animal welfare groups, and pet owners. The global spay and neuter market is segmented - 1) By Animal Type: Dogs, Cats, Other Animals 2) By Provider Type: Veterinary Clinics And Hospitals, Other Providers 3) By End-User: Animal Welfare Groups, Pet Owners The global spay and neuter market size is expected to grow from $2.11 billion in 2022 to $2.24 billion in 2023 at a compound annual growth rate (CAGR) of 5.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global spay and neuter market size is expected to reach $2.6 billion in 2027 at a CAGR of 4.7%. An increase in pet adoption will propel the growth of the spay and neuter market going forward. Animal adoption is defined as acquiring animals through rescue groups instead of purchasing them from pet shops or breeders. Spaying and neutering are used by animals for protection against various diseases and medical conditions and from unwanted births. For instance, in 2021, according to Chewy, Inc., a US-based online retailer of pet food and other products, there were around 977,202 pets adopted in the US in 2021, which resulted in the highest adoption rate of 61% in the past six years. For another instance, in November 2022, according to a national survey of pets and people published by Animal Medicines Australia (AMA), an Australia-based industry body representing the leaders of the animal health industry in Australia, in 2022, 48% of households had dogs, up from 40% in 2019. According to the 2021–2022 APPA National Pet Owners Survey, 90.5 million American households, or about 70% of all houses, have a pet. Therefore, the rise in the rate of animal adoption is driving the growth of the spay and neuter market. Major players in the spay and neuter market are CVS Group Plc, VetPartners Group Limited, Ethos Veterinary Health LLC, PetIQ, Covetrus, Inc., Zoetis Inc., VCA Animal Hospitals, Veritas Veterinary Partners, AniCura AB, and Dash Solutions. Product innovations are a key trend gaining popularity in the spay and neuter market. Major market players are concentrating their efforts on introducing new and advanced products to strengthen their position in the market. For instance, in July 2022, Virbac, a France-based animal health products and pharmaceuticals company launched VETERINARY HPM®, which is a unique nutritional line of food products specifically for spayed and neutered pets. This line of food products is made with special resources to provide nutritional value for pets after undergoing spaying and neutering procedures. In February 2021, Auburn Valley Humane Society, a US-based animal shelter, merged with Northwest Spay & Neuter Center. This merger positively affected animal lives in Washington and increased the stabilized funding streams for total animal impact in the state. The merger helped the organizations to diversify, to become more financially stable, and increased the breadth of granting and funding eligibility of the organizations. Northwest Spay & Neuter Center is a US-based center that offers affordable spay and neuter services. North America was the largest region in the spay and neuter market in 2022. Asia-Pacific is expected to be the fastest-growing region in the global spay and neuter market report during the forecast period. The regions covered in the global spay and neuter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the spay and neuter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The spay and neuter market include revenues earned by entities by ovariohysterectomy, orchiectomy, hysterectomy, and vasectomy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The spay and neuter market research report is one of a series of new reports from The Business Research Company that provides spay and neuter market statistics, including spay and neuter industry global market size, regional shares, competitors with a spay and neuter market share, detailed spay and neuter market segments, market trends and opportunities, and any further data you may need to thrive in the spay and neuter industry. This spay and neuter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Feed additives refer to animal nutrition products that are used to improve the quality of animal food, in addition to animals' performance and health. Feed additives contain numerous chemicals, substances, or organisms that increase nutritional ingestion, absorption, and assimilation. The main product types of feed additives are amino acids, phosphates, vitamins, acidifiers, carotenoids, enzymes, mycotoxin detoxifiers, flavors and sweeteners, antibiotics, and others. Amino acids are molecules that combine to form proteins. The various livestock involved is poultry, ruminants, swine, aquatic animals, and others which are obtained from synthetic and natural sources in liquid and dry form. The global feed additives market is segmented - 1) By Product Type: Amino Acids, Phosphates, Vitamins, Acidifiers, Carotenoids, Enzymes, Mycotoxin Detoxifiers, Flavors And Sweeteners, Antibiotics, Other Products 2) By Livestock: Poultry, Ruminants, Swine, Aquatic Animals, Other livestock 3) By On Source Type: Synthetic, Natural 4) By Form: Liquid, Dry The global feed additives market size is expected to grow from $18.28 billion in 2022 to $19.88 billion in 2023 at a compound annual growth rate (CAGR) of 8.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global feed additives market size is expected to reach $25.83 billion in 2027 at a CAGR of 6.8%. The growing meat and dairy products are expected to propel the growth of the feed additives market going forward. Meat, which is defined as the flesh of animals (including fish and birds) that is consumed as food and can be a part of a healthy diet, and dairy products include milk and any milk-based foods such as butter, cheese, ice cream, etc. Feed additives are products that are added to animal feed to help meet the animals' nutritional needs. It encourages the production of meat and dairy products in order to improve the quality of animal feed and food. For instance, in May 2022, according to a report published by Government of Canada official website, Canadian consumers' per capita meat consumption was Can$601.1 in 2021, up from Can$523.9 in 2017, and is expected to rise to Can$723.1 by 2026. Therefore, growing meat and dairy products are driving the growth of the feed additives market. Major players in the feed additives market are Cargill Incorporated, Archer Daniels Midland (ADM) Company, DuPont de Nemours Inc., Evonik Industries AG, BASF SE, Koninklijke DSM N.V., Novozymes A/S, Chr. Hansen A/S, Nutreco N.V., Kemin Industries Inc., Alltech, Ajinomoto Co.Inc., Adisseo Co, Tegasa, Palital Feed Additives B.V., and Solvay S.A. Major companies operating in feed additives are focused on developing innovative solutions to strengthen their position in the market. For instance, in February 2021, Kemin Industries Inc., a US-based manufacturer of specialty ingredients for several industries, including human/animal health and nutrition, pet food, aquaculture, launched KemTRACE Chromium-OR, a water-soluble, highly bioavailable, organic-compliant chromium propionate feed ingredient for use in swine, cattle, broiler, and horse diets. It helps in improving the maintenance, reproduction, growth, and immunity of swine, cattle, broilers, and horses. Additionally, it improves glucose utilization and reduces the negative impacts of stress for increased cellular energy and function in animals. In June 2022, Cargill Incorporated, a US-based agribusiness and animal nutrition company, acquired Delacon Biotechnik Ges.m.b.H. for an undisclosed amount. Through this acquisition, Cargill Incorporated aims to expand its portfolio with significant experience in feed additives, a global footprint, and assistance in the production of more nutritious food, which will improve livestock and aquaculture performance and promote animal health. Delacon Biotechnik Ges.m.b.H., is an Austria-based feed additive company. Asia-Pacific was the largest region in the feed additives market in 2022. The regions covered in the global feed additives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the feed additives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The feed additives market consists of sales of sensory feed additives, nutritional feed additives, zootechnical feed additives, and coccidiostats and histomonostats feed additives. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The feed additives market research report is one of a series of new reports from The Business Research Company that provides feed additives market statistics, including feed additives industry global market size, regional shares, competitors with feed additives market share, detailed feed additives market segments, market trends, and opportunities, and any further data you may need to thrive in the feed additives industry. This feed additives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Pet diabetes care devices are medical devices to treat pet diabetes through routine check-ups, blood and urine testing, and observation of the animal's weight, appetite, drinking, and urination. These devices control diabetic pets by keeping their blood sugar levels close to normal and preventing dangerously high or low levels. The main animal types in the market for pet diabetes care devices are dogs, cats, and horses. A dog is a four-legged creature that is frequently kept as a pet or employed for hunting. Pet diabetes care devices are used to monitor the health of diabetic dogs. The devices are glucose monitoring devices and insulin delivery devices, used by homecare, veterinary hospitals and others. The global pet diabetes care devices market is segmented - 1) By Animal Type: Dogs, Cats, Horses 2) By Device: Glucose Monitoring Devices, Insulin Delivery Devices 3) By End Users: Homecare, Veterinary Hospitals, Others End Users The global pet diabetes care devices market size is expected to grow from $2.25 billion in 2022 to $2.42 billion in 2023 at a compound annual growth rate (CAGR) of 7.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global pet diabetes care devices market size is expected to reach $3.2 billion in 2027 at a CAGR of 7.3%. Increasing pet health expenditure is expected to propel the growth of the pet diabetes care device market going forward. Pet health expenditure refers to the amount of money spent by owners on their pets' health issues. The expenditure for pet healthcare includes the veterinary care, equipment, and pet healthcare devices required. For instance, in October 2022, according to the data released by the American Veterinary Medical Association, a US-based non-profit organization, between 2020 and 2022, Consumer spending on dogs and cats has increased across the board. Yearly veterinarian visit expenditures for households with one dog grew from $224 in 2020 to $362 in 2022. In 2020, the average annual expenditure on veterinarian visits for homes with cats was $189, rising to $321 in 2022. Therefore, the increasing pet health expenditure is driving the growth of the pet diabetes care device market. Major players in the pet diabetes care devices market are Allison Medical Inc., Zoetis Inc., Becton, Dickinson and Company, Boehringer Ingelheim Vetmedica Inc., Henry Schein Animal Health, MedTrust LLC, Merck & Co Inc., UltiMed Inc., TaiDoc Technology Corp, ALR Technologies Inc., I-SENS. Inc., Teco Diagnostics, FitBark, and AccuBioTech Co Ltd. Technological advancements are a key trend in the pet diabetes care device market. Major companies operating in the pet diabetes care device market are developing innovative technologies to strengthen their position in the market. For instance, in October 2020, Trividia Health, a US-based manufacturer of pet diabetes care devices, launched Test Buddy. The Test Buddy's unique features include Bluetooth technology that uploads data to the Test Buddy App on IOS or Android platforms. It is designed to monitor a pet's glucose levels and share results and trending data with a veterinarian. In September 2022, Zoetis, a US-based manufacturer of pet medicine vaccinations, acquired NewMetrica for an undisclosed amount. With this acquisition, Zoetis will utilize the tools of NewMetrica's algorithms to enable earlier disease identification and treatment as they gain greater knowledge of pet quality of life and become a crucial component of future product development. NewMetrica is a UK-based company operating in pet diabetes care devices. North America was the largest region in the pet diabetes care devices market in 2022. The regions covered in the global pet diabetes care device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pet diabetes care device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The pet diabetes care device market consists of sales of insulin delivery devices, insulin delivery pen amd insulin syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The pet diabetes care devices market research report is one of a series of new reports from The Business Research Company that provides pet diabetes care devices market statistics, including global market size, regional shares, competitors with a pet diabetes care devices market share, detailed pet diabetes care devices market segments, market trends and opportunities, and any further data you may need to thrive in the pet diabetes care devices industry. This pet diabetes care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Veterinary telehealth refers to any use of technology to provide health information, education, or remote care for vets. Veterinary telehealth involves the use of electronic medical information interchange from one site to another to improve and analyze animals' overall health status. The main animal types in veterinary telehealth are canine, feline, equine, bovine, swine, and others. Canine animals are mammals with snouts, nonretractable claws, and frequently long muzzles. It is available in service types such as telemedicine, teleconsulting, and telemonitoring and others. It evolves various applications such as computed tomography (CT) reporting, radiographic reporting, X-ray and picture archiving and communication system (PACS) advice, magnetic resonance imaging (MRI) reporting, and others. The global veterinary telehealth market is segmented - 1) By Animal Type: Canine, Feline, Equine, Bovine, Swine, Other Animal Types 2) By Service Type: Telemedicine, Teleconsulting, Telemonitoring, Other Service Types 3) By Application: Computed Tomography (CT) Reporting, Radiographic Reporting, X-Ray And Picture Archiving And Communication System (PACS) Advice, Magnetic Resonance Imaging (MRI) Reporting, Other Applications The global veterinary telehealth market size is expected to grow from $3.15 billion in 2022 to $3.77 billion in 2023 at a compound annual growth rate (CAGR) of 19.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global veterinary telehealth market size is expected to reach $7.43 billion in 2027 at a CAGR of 18.4%. The growing prevalence of zoonotic diseases in animals is expected to propel the growth of the veterinary healthcare market going forward. Zoonotic diseases are a group of common diseases caused by pathogenic germs such as viruses, bacteria, parasites, and fungi. These viruses can cause various ailments in humans and animals, from moderate to severe illness and even death. Veterinary telemedicine services can help to reduce zoonotic infections in animals by enabling disease detection and management. Veterinarians can discover and diagnose diseases in their early stages by providing virtual consultations with pet owners, thereby limiting the spread of zoonotic infections. For instance, in July 2022, according to an article published by the world health organization, a US-based government agency, states that there was a 64% rise in the number of zoonotic cases in Africa. Furthermore, zoonotic illnesses are on the increase both internationally and in India. These emerging infectious diseases in humans account for 60% of cases, with 816 zoonotic pathogens out of 1407 human pathogens. Therefore, the growing prevalence of zoonotic disease in animals will drive the veterinary telehealth market. Major players in the veterinary telehealth market are Airvet Inc., Activ4Pets LLC, BabelBark Inc., GuardianVets Inc., PetDesk, TeleTails, TeleVet, Vetster Inc., VitusVet, Whiskers Worldwide LLC, Virtuwoof LLC, FirstVet, PawSquad, Petriage Inc., Petzam Inc., and Animan Technologies Inc. Product innovations are a key trend for gaining popularity in the veterinary telehealth market. Major companies operating in the veterinary telehealth market are focused on developing innovative solutions to strengthen their position in the market. For instance, in October 2020, Chewy Inc., a US-based pet e-commerce retailer of pet-related items, will introduce a new telehealth service, Connect With a Vet, which allows pet owners and veterinarians to use the company's unique tele-triage technology to maintain continuous veterinary care and support. With this new service, pet parents may speak directly with a licensed veterinarian to obtain answers to their questions, obtain advice, address concerns about their pet's health and welfare, and even seek recommendations to local doctors or emergency clinics. The simplicity of use and convenience of this tele-triage solution will have a favorable influence, making it unique. Chewy Inc.'s introduction of Connect With a Vet promises to revolutionize how pet owners access veterinary care. In November 2020, Pets at Home, a UK-based pet care business providing food, toys and bedding, grooming services, and veterinary services, acquired The Vet Connection for £ 15 million ($17.90 million). The acquisition of The Vet Connection is a significant step toward the growth of Pets at Home's digital capabilities, which will provide trustworthy guidance and even more accessible pet care services. The Vet Connection (TVC) is a UK-based provider of independent veterinary telehealth. North America was the largest region in the veterinary telehealth market in 2022. Asia-Pacific is expected to be the fastest-growing region in the global veterinary telehealth market report during the forecast period. The regions covered in the global veterinary telehealth market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the veterinary telehealth market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The veterinary telehealth market consists of revenues earned by entities by providing veterinary healthcare services such as telemedicine, teleconsulting, telemonitoring, tele advice, teletriage, e-prescribing, and mhealth. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The veterinary telehealth market research report is one of a series of new reports from. The Business Research Company that provides veterinary telehealth market statistics, including veterinary telehealth industry global market size, regional shares, competitors with a veterinary telehealth market share, detailed veterinary telehealth market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary telehealth industry. This veterinary telehealth market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.